0001883850-22-000032.txt : 20220401
0001883850-22-000032.hdr.sgml : 20220401
20220401160841
ACCESSION NUMBER: 0001883850-22-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220330
FILED AS OF DATE: 20220401
DATE AS OF CHANGE: 20220401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDSTEIN JOSEPH L
CENTRAL INDEX KEY: 0001225474
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 22798284
MAIL ADDRESS:
STREET 1: DEPT OF PHARMACOLOGY K5 YUVER OF TEXAS
STREET 2: 5323 HARRY HINES BLVD
CITY: DALLAS
STATE: TX
ZIP: 75390
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-03-30
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001225474
GOLDSTEIN JOSEPH L
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2022-03-30
4
M
0
2431
374.12
A
8513
D
Common Stock
2022-03-30
4
S
0
2431
700.0
D
6082
D
Non-Qualified Stock Option (right to buy)
374.12
2022-03-30
4
M
0
2431
0.0
D
2030-01-02
Common Stock
2431
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant.
/s/**Joseph L. Goldstein
2022-03-31